Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,514 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,514 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,514 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,514 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,514 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,514 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,514 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
28 Jan 2026
Maria G Freve See Remarks
Sold on a plan 4×
$457.72K 8,306 at 55.11
93.9%
Sold half or more
28 Jan 2026
Donald Michael Westermann Chief Information Officer
Sold at will
$427.46K 21,256 at 20.11
50.5%
Sold half or more
28 Jan 2026
John F Wilson Executive Chairman
Sold at will
$335.76K 5,344 at 62.83
0.9%
Not planned
28 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$285.19K 1,200 at 237.66
0.8%
Planned (10b5-1)
28 Jan 2026
Jon Christianson President
Sold at will
$238.68K 1,991 at 119.88
3.1%
Not planned
28 Jan 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$237.66K 1,000 at 237.66
0.4%
Planned (10b5-1)
28 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$220.55K 928 at 237.66
0.5%
Planned (10b5-1)
28 Jan 2026
Margaret Hayne Co-President & CCO · indirect
Sold on a plan
$202.44K 2,890 at 70.05
0.1%
Planned (10b5-1)
28 Jan 2026
Jonathan Knutzen Chief Risk Officer
Sold at will
$184.02K 1,535 at 119.88
5.8%
Not planned
28 Jan 2026
Angela L. Grant Chief Legal Officer
Sold at will
$173.47K 1,447 at 119.88
21.6%
Not planned
28 Jan 2026
Mary Clara Capel Retired Board Member
Sold at will 4×
$143.14K 2,500 at 57.26
8.2%
Not planned
28 Jan 2026
Camellia E FitzGerald Chief Accounting Officer
Sold on a plan
$134.88K 2,810 at 48.00
22.0%
Planned (10b5-1)
28 Jan 2026
Sold at will 2×
$129.53K 9,349 at 13.86
2.9%
Not planned
28 Jan 2026
William Yeung Chief Legal Officer
Sold on a plan
$105.79K 7,271 at 14.55
7.5%
Planned (10b5-1)
28 Jan 2026
Steven Yi See Remarks
Sold on a plan
$84.59K 8,000 at 10.57
0.3%
Planned (10b5-1)
28 Jan 2026
Elizabeth B Chandler CLO, GC, Corporate Secretary
Sold at will
$83.50K 1,329 at 62.83
2.2%
Not planned
28 Jan 2026
Kyle Owen Mooney SVP - Chief Operating Officer
Sold at will
$63.66K 2,808 at 22.67
16.5%
Not planned
28 Jan 2026
Tim Watkins CMO & Head of Development
Sold on a plan 2×
$51.19K 3,611 at 14.18
100%
Sold half or more
28 Jan 2026
Patrick M Joyce EVP and CLO
Sold at will 2×
$30.60K 4,000 at 7.65
6.9%
Not planned
28 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$23.19K 6,500 at 3.57
100%
Sold half or more
28 Jan 2026
Donald A Bergstrom President, R&D
Sold at will
$22.70K 2,686 at 8.45
0.6%
Not planned
28 Jan 2026
Shane Thomas Gleason Chief Commercial Officer
Sold at will
$20.46K 12,395 at 1.65
1.1%
Not planned
28 Jan 2026
Thomas D Tesh Chief Admin. Officer
Sold at will
$20.29K 323 at 62.83
1.1%
Not planned
28 Jan 2026
John R Gallagher Chief Operating Officer
Sold on a plan
$13.62K 430 at 31.67
1.3%
Planned (10b5-1)
28 Jan 2026
Peter Rahmer See remarks
Sold at will
$11.44K 1,354 at 8.45
0.5%
Not planned
28 Jan 2026
Derek M Meisner Chief Legal Officer & Corp Sec
Sold on a plan
$8.02K 2,671 at 3.00
1.5%
Planned (10b5-1)
28 Jan 2026
Kristin Abate Chief Accounting Officer
Sold at will
$351.50 50 at 7.03
0.2%
Not planned
27 Jan 2026
Michael Charles Ray SVP, Chief Legal Officer
Sold on a plan 13×
$5.03M 12,268 at 409.68
14.1%
Planned (10b5-1)
27 Jan 2026
Earl H Nemser Vice Chairman · indirect
Sold at will 2×
$4.53M 60,200 at 75.30
100%
Sold half or more
27 Jan 2026
Carey Halio Global Treasurer
Sold at will 12×
$2.64M 2,846 at 927.17
58.5%
Sold half or more
27 Jan 2026
Louise Frederika Kooij Chief Accounting Officer
Sold on a plan
$1.30M 39,816 at 32.62
62.0%
Sold half or more
27 Jan 2026
Johnson McCallum Green Chief Client Officer
Sold at will
$747.45K 61,016 at 12.25
5.3%
Not planned
27 Jan 2026
Artur Bergman Chief Technology Officer
Sold on a plan
$512.93K 49,320 at 10.40
1.9%
Planned (10b5-1)
27 Jan 2026
Brady K Long EVP & Chief Legal Officer
Sold on a plan
$496.47K 99,293 at 5.00
8.7%
Planned (10b5-1)
27 Jan 2026
Seth D Krauss See Remarks
Sold on a plan 4×
$455.80K 2,271 at 200.71
100%
Sold half or more
27 Jan 2026
Ronald L Phillips EVP and CHRO
Sold on a plan
$453.68K 5,601 at 81.00
13.5%
Planned (10b5-1)
27 Jan 2026
Arturo Md Molina Chief Medical Officer
Sold at will
$410.00K 5,000 at 82.00
5.6%
Not planned
27 Jan 2026
Ajay Ayyappan EVP & Gen Counsel/Corp. Sec'y.
Sold on a plan 2×
$345.09K 8,114 at 42.53
13.2%
Planned (10b5-1)
27 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$243.66K 1,013 at 240.53
0.7%
Planned (10b5-1)
27 Jan 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$213.11K 886 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Jens Frank Ruppert EVP Canvys
Sold at will 3×
$205.48K 17,000 at 12.09
30.1%
Not planned
27 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$188.58K 784 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Amy M Butler EVP, National Sales
Sold at will 2×
$178.58K 9,911 at 18.02
60.9%
Sold half or more
27 Jan 2026
David Jedrzejek SVP and General Counsel
Sold on a plan
$151.65K 7,093 at 21.38
6.7%
Planned (10b5-1)
27 Jan 2026
Donald A Bergstrom President, R&D
Sold at will
$143.98K 18,895 at 7.62
4.3%
Not planned
27 Jan 2026
Margaret Hayne Co-President & CCO · indirect
Sold on a plan
$126.98K 1,814 at 70.00
0.1%
Planned (10b5-1)
27 Jan 2026
Myriam Curet EVP & Chief Medical Officer
Sold on a plan 2×
$122.50K 230 at 532.61
100%
Sold half or more
27 Jan 2026
Casey O'Connor Chief Legal Officer
Sold on a plan
$109.89K 19,347 at 5.68
3.4%
Planned (10b5-1)
27 Jan 2026
Kelly Costanza Chief People Officer
Sold at will 2×
$106.08K 1,707 at 62.14
1.4%
Not planned
27 Jan 2026
Teresa Brophy Bair Chief Legal Officer
Sold at will 3×
$94.83K 11,208 at 8.46
4.7%
Not planned
Showing 16,401–16,450 of 20,514. ← Newer Page 329 of 411 Older →